117 related articles for article (PubMed ID: 19596602)
1. Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates.
Li W; Tang Y; Hoshino T; Neya S
J Mol Graph Model; 2009 Sep; 28(2):170-6. PubMed ID: 19596602
[TBL] [Abstract][Full Text] [Related]
2. Computational identification and binding analysis of orphan human cytochrome P450 4X1 enzyme with substrates.
Kumar S
BMC Res Notes; 2015 Jan; 8():9. PubMed ID: 25595103
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic properties of human CYP2W1 expressed in Escherichia coli.
Yoshioka H; Kasai N; Ikushiro S; Shinkyo R; Kamakura M; Ohta M; Inouye K; Sakaki T
Biochem Biophys Res Commun; 2006 Jun; 345(1):169-74. PubMed ID: 16677611
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
Clin Cancer Res; 2013 Jun; 19(11):2952-61. PubMed ID: 23589180
[TBL] [Abstract][Full Text] [Related]
7. Construction of a 3D model of cytochrome P450 2B4.
Chang YT; Stiffelman OB; Vakser IA; Loew GH; Bridges A; Waskell L
Protein Eng; 1997 Feb; 10(2):119-29. PubMed ID: 9089811
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.
Bart AG; Morais G; Vangala VR; Loadman PM; Pors K; Scott EE
Drug Metab Dispos; 2022 Jan; 50(1):49-57. PubMed ID: 34607808
[TBL] [Abstract][Full Text] [Related]
9. Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.
Guo J; Thiess S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
FEBS Lett; 2016 Feb; 590(3):330-9. PubMed ID: 26787547
[TBL] [Abstract][Full Text] [Related]
10. Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies.
Ducassou L; Jonasson G; Dhers L; Pietrancosta N; Ramassamy B; Xu-Li Y; Loriot MA; Beaune P; Bertho G; Lombard M; Mansuy D; André F; Boucher JL
Biochim Biophys Acta; 2015 Jul; 1850(7):1426-37. PubMed ID: 25857771
[TBL] [Abstract][Full Text] [Related]
11. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
[TBL] [Abstract][Full Text] [Related]
12. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.
Wu ZL; Sohl CD; Shimada T; Guengerich FP
Mol Pharmacol; 2006 Jun; 69(6):2007-14. PubMed ID: 16551781
[TBL] [Abstract][Full Text] [Related]
13. Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors.
Choong E; Guo J; Persson A; Virding S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
PLoS One; 2015; 10(4):e0122820. PubMed ID: 25844926
[TBL] [Abstract][Full Text] [Related]
14. Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.
Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
PLoS One; 2016; 11(9):e0162379. PubMed ID: 27598485
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of cytochrome P450 1A1: enzyme-substrate interactions and substrate binding affinities.
Szklarz GD; Paulsen MD
J Biomol Struct Dyn; 2002 Oct; 20(2):155-62. PubMed ID: 12354067
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling, binding site identification and docking in flavone hydroxylase CYP105P2 in Streptomyces peucetius ATCC 27952.
Kanth BK; Liou K; Sohng JK
Comput Biol Chem; 2010 Aug; 34(4):226-31. PubMed ID: 20889382
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies.
Meng XY; Zheng QC; Zhang HX
Biochim Biophys Acta; 2009 Jul; 1794(7):1066-72. PubMed ID: 19358898
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling study on orphan human protein CYP4A22 for identification of potential ligand binding site.
Gajendrarao P; Krishnamoorthy N; Sakkiah S; Lazar P; Lee KW
J Mol Graph Model; 2010 Feb; 28(6):524-32. PubMed ID: 20079672
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?
Pan Y; Ong EC
Xenobiotica; 2017 Oct; 47(10):923-932. PubMed ID: 27690753
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Ramón y Cajal S; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Mar; 341(2):451-8. PubMed ID: 16426568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
